Novartis raises 2023 forecast, maps out Sandoz spin-off
(Reuters) – Novartis on Tuesday raised its full-year earnings forecast on strong drug sales and mapped out the planned spin-off…
(Reuters) – Novartis on Tuesday raised its full-year earnings forecast on strong drug sales and mapped out the planned spin-off…
(Reuters) – Eli Lilly’s experimental drug donanemab slowed the progression of Alzheimer’s by 60% for patients in the earliest stages…
(Reuters) – U.S. startup Fisker (NYSE:FSR) said on Monday it would produce 100 limited edition electric sports utility vehicles (SUVs)…
Bank of America reiterated a Neutral rating on Lucid Group (NASDAQ:LCID) with a 12-month price target of $8.00 after the…
(Reuters) – Germany’s top union IG Metall on Monday called for Tesla (NASDAQ:TSLA) to improve staffing conditions at its German…
(Reuters) -Wall Street’s main stock indexes were on course for a lower open on Monday after last week’s strong gains,…
Brunswick (NYSE:BC) was cut to Sector Weight from Overweight, while YETI Holdings (NYSE:YETI) was moved to Underweight from Sector Weight…
Wells Fargo reiterated an Equal Weight rating on Tesla (NASDAQ:TSLA) and raised their 12-month price target on the stock to…
EU antitrust authorities will open an investigation next week into whether Microsoft (NASDAQ:MSFT) is unfairly bundling its Teams video conferencing…
Evercore ISI analysts previewed Netflix’s (NASDAQ:NFLX) upcoming second-quarter earnings print. They see the potential for a pullback in NFLX stock…